Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Other 2

Conditions

Opioid-Induced Constipation 2Neoplasms 1

Interventions

Surveys and Questionnaires 9Blood Specimen Collection 5naloxegol 3Therapeutics 3Observation 3Interviews as Topic 3Bariatric Surgery 3naldemedine 2exemestane 2Tirzepatide 2Tamoxifen 2Psychiatric Rehabilitation 2Paclitaxel 2Hematologic Tests 2Esophagectomy 2Echocardiography 2Carboplatin 2Biopsy 2BaseLine dental cement 2Anastrozole 2trametinib 1sotorasib 1semaglutide 1selpercatinib 1pembrolizumab 1osimertinib 1lorlatinib 1dabrafenib 1cemiplimab 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × naldemedine × Other × Clear all
NCT07231796 2026-01-02

NOCON

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Recruiting
100 enrolled
Other

Opioid-Induced Constipation, Neoplasms

NCT03720613 2025-02-12

Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation

BioDelivery Sciences International

Recruiting
34,532 enrolled
Other

Opioid-Induced Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡